Scandinavian ChemoTech AB utser ny tf. CFO
ChemoTech har glädjen att meddela att Annette Colin tillträder som ny tf. CFO.
Read moreLatest News & Press Releases in Swedish
Latest Videos
Scandinavian ChemoTech AB publicerar delårsrapport för januari-juni 2019
Ett kvartal med en del framsteg
Read moreShare analysis ChemoTech Q2 2018
Share Day in Malmö on May 22, 2018
Our foundation
Our profound knowledge in Electroporation forms the starting point for the company’s existing product and R&D projects : IQwave™ specially desinged for both Dynamic-ElectroEnhanced Chemotherapy and the first generation Electrochemotherpy for the treatment of a range of different types of tumors.
Our research focus
Our aim is to document the effects of elctrochemotherapy for pain management for cancer patients, an area with significant unmet medical need.
Gentle cancer treatment
Our ECT treatment is normally performed under local anaesthesia and light sedation, which makes it a very gentle treatment option. One unique feature of our therapy is that it can be adapted to individual tumour characteristics.